Fig. 3
From: RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells

Effects of RNF138 on the apoptosis of cisplatin-treated NPC cells. (A) The apoptosis rate of cisplatin-treated 5–8 F and SUNE-2 cells that were transfected with OE-NC or OE-RNF138 was assessed by flow cytometry analysis. (B) The apoptosis rate of cisplatin-treated 5–8 F and SUNE-2 cells that were transfected with si-NC or siRNA1/2 was assessed by flow cytometry analysis. **P < 0.01, ***P < 0.001.